Skip to content
Screener

Total Equity at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$6.38B-1.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$84.97B+8.3%
Staar Surgical logo
Staar SurgicalSTAA
$352.37M+0.7%
Apyx Medical Corporation logo
Apyx Medical CorporationAPYX
$12.83M+22.1%
Ardelyx logo
ArdelyxARDX
$149.01M+6.8%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
-$161.84M+47.5%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.21B+3.8%
Enterprise value$21.66B-2.1%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemMarch 31,2026December 31,2025
Common shares, no par value, unlimited shares authorized, 373,464,760 and 370,531,987 issued and outstanding at March 31, 2026 and December 31, 2025, respectively10,54210,516
Additional paid-in capital295357
Accumulated deficit(11,090)(9,667)
Accumulated other comprehensive loss(1,806)(1,760)
Total Bausch Health Companies Inc. shareholders’ deficit(2,059)(554)
Noncontrolling interest977931
Total (deficit) equity(1,082)377
Total liabilities and equity$24,498$26,366

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's total equity?
Bausch Health Companies (BHC) reported total equity of -$2.06B in Q1 2026.
How has Bausch Health Companies's total equity changed year-over-year?
Bausch Health Companies's total equity decreased by 74.0% year-over-year, from -$1.18B to -$2.06B.
What is the long-term trend for Bausch Health Companies's total equity?
Over 5 years (2020 to 2025), Bausch Health Companies's total equity has grown at a 0.7% compound annual growth rate (CAGR), from $535M to -$554M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Bausch Health Companies's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude